Wetenschappelijke artikelen zoeken
Wetenschappelijke artikelen over borstkanker bij mannen kunnen gezocht worden via pubmed https://www.ncbi.nlm.nih.gov/pubmed/.
Uitleg gebruik zoektermen pubmed
In PubMed wordt gezocht in drie verschillende zoekvelden:
1. MeSH termen
2. Titel
3. Abstract (samenvatting)
MeSH (medical subject headings) termen zijn simpelweg onderwerpen die aan een artikel zijn gegeven om te zorgen dat de database geordend blijft. Op basis van een combinatie van deze termen kunnen artikelen gevonden worden over een bepaald onderwerp. Omdat het toekennen van deze termen nog handmatig gebeurt, zit er een vertraging in het toekennen aan artikelen. Dat is de reden dat er ook in de titel en abstract (samenvatting) van een artikel wordt gezocht ([tiab]). Door hierin te zoeken, komt alle recente literatuur ook in de zoekopdracht. Naast recente literatuur, kan er door middel van zoeken in de titel en abstract ook artikelen vinden die synoniemen gebruiken. Een voorbeeld daarvan is dat “kanker (cancer)” ook wel neoplasma, tumor of carcinoom wordt genoemd. Meer informatie over gebruik zoektermen in pubmed: https://www.nlm.nih.gov/bsd/mms/medlineelements.html
Zoekblokken
Hieronder 6 verschillende zoekblokken met combinaties van zoektermen die gebruikt kunnen worden om Nederlandse en Engelse artikelen over borstkanker bij mannen (Male Breast Cancer(MBC)) te vinden op pubmed. Om te zoeken in pubmed kunnen de zoekblokken gekopieerd worden in de zoekbalk. De meest recente artikelen komen bovenaan te staan.
1. Mannen met borstkanker en psychologie/stigma
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab]) AND (“Psychology”[Mesh] OR psychol* [tiab] OR psychosocia* [tiab] OR psycho-socia* [tiab] OR stigma* [tiab] OR taboo* [tiab] OR masculin* [tiab] OR (cultur* [tiab] AND (belief* [tiab] OR believ* [tiab] OR perspect* [tiab] OR percept*[tiab]))) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/
2. Mannen met borstkanker en clinical trials
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab]) AND (“Clinical Trials, Phase I as Topic”[Mesh] OR “Clinical Trials, Phase II as Topic”[Mesh] OR “Clinical Trials, Phase III as Topic”[Mesh] OR “Clinical Trials, Phase IV as Topic”[Mesh] OR phase I [tiab] OR phase 1 [tiab] OR phase II [tiab] OR phase 2 [tiab] OR phase III [tiab] OR phase 3 [tiab] OR phase IV [tiab] OR phase 4 [tiab] OR “Clinical Trials, Phase I as Topic”[Mesh] OR “Clinical Trials, Phase II as Topic”[Mesh] OR “Clinical Trials, Phase III as Topic”[Mesh] OR “Clinical Trials, Phase IV as Topic”[Mesh] OR “Randomized Controlled Trial” [Publication Type] OR “Randomized Controlled Trials as Topic”[Mesh] OR ((randomized [tiab] OR randomized [tiab]) AND (clinical trial* [tiab] OR controlled trial* [tiab])) OR RCT* [tiab] OR (random*[tiab] AND (controlled[tiab] OR control[tiab] OR placebo[tiab] OR versus[tiab] OR vs[tiab] OR group[tiab] OR groups[tiab] OR comparison[tiab] OR compared[tiab] OR arm[tiab] OR arms[tiab] OR crossover[tiab] OR cross-over[tiab]) AND (trial[tiab] OR study[tiab])) OR ((single[tiab] OR double[tiab] OR triple[tiab]) AND (masked[tiab] OR blind*[tiab])) OR “Prospective Studies”[Mesh] OR prospective study [tiab] OR prospective studies [tiab] OR “Retrospective Studies”[Mesh] OR Retrospective study [tiab] OR Retrospective studies [tiab]) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/
3. Mannen met borstkanker en Overleving (Survival)
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab]) AND (“Survival Analysis”[Mesh] OR “Survival Rate”[Mesh] OR “Prognosis”[Mesh:NoExp] OR “Incidence”[Mesh] OR survival analys* [tiab] OR overall survival [tiab] OR survival rate* [tiab] OR survival time* [tiab] OR (survival* [tiab] AND (disease free [tiab] OR event free [tiab] OR progression free [tiab])) OR prognosis [tiab] OR prognoses [tiab] OR incidence* [tiab] OR “Disease-Free Survival”[Mesh] OR “Survival Rate”[Mesh] OR (survival [tiab] AND (rate* [tiab] OR time* [tiab]))) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/
4. Mannen met borstkanker en Fundamenteel en Translationeel onderzoek
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab]) AND (“Translational Medical Research”[Mesh] OR (translation* [tiab] AND (research [tiab] OR knowledge [tiab] OR science* [tiab])) OR “Biomarkers”[Mesh] OR biomarker* [tiab] OR predictor* [tiab] OR biological marker* [tiab] OR bio-marker* [tiab] OR serum marker* [tiab] OR Surrogate Endpoint* [tiab] OR Surrogate End-point* [tiab] OR viral marker* [tiab] OR immune marker* [tiab] OR immunologic marker* [tiab] OR surrogate marker* [tiab] OR biochemical marker* [tiab] OR biologic marker* [tiab] OR “Genetic Techniques”[Mesh] OR genetic techni* [tiab] OR genetic profil* [tiab] OR DNA Fingerprint* [tiab] OR Gene Target* [tiab] OR “Gene Expression”[Mesh] OR gene expression* [tiab] OR expression of gene* [tiab] OR “Antineoplastic Agents, Hormonal”[Mesh] OR Hormonal Antineoplastic [tiab] OR “Antineoplastic Agents”[Mesh] OR Antineoplastic* [tiab] OR anti-cancer drug* [tiab] OR anti-cancer agent* [tiab] OR anti-tumor drug* [tiab] OR anti-cancer agent* [tiab] OR “DNA Damage”[Mesh] OR ((DNA [tiab] OR chromosom* [tiab]) AND (damag* [tiab] OR injury [tiab] OR injuries [tiab] OR adduct* [tiab] OR break [tiab] OR breaks [tiab] OR degredat* [tiab] OR fragment* [tiab])) OR genotoxic stress* [tiab] OR “DNA Repair”[Mesh] OR “DNA Mismatch Repair”[Mesh] OR “DNA End-Joining Repair”[Mesh] OR “Recombinational DNA Repair”[Mesh] OR (repair* [tiab] AND (DNA [tiab] OR DNA mismatch [tiab] OR mismatch* [tiab] OR excision [tiab] OR recombination* [tiab] OR break [tiab] OR end joining [tiab] OR end-joining [tiab] OR MMEJ [tiab])) OR DNA end-joining [tiab] OR DNA end joining [tiab] OR repair* [tiab] OR NHEJ [tiab] OR NER [tiab] OR BER [tiab] OR “Biochemical Phenomena”[Mesh] OR (biochemical [tiab] AND process* [tiab]) OR “Biochemical Phenomena”[Mesh] OR (biochemical [tiab] AND (concept* [tiab] OR phenomen* [tiab])) OR “Molecular Biology”[Mesh] OR (molecular [tiab] AND (biology [tiab] OR genetic* [tiab])) OR (biochemical [tiab] AND genetic* [tiab]) OR hormonal therap* [tiab] OR endocrine therap* [tiab] OR anti-hormonal therap* [tiab] OR anti-hormonal drug* [tiab] OR hormonal drug* [tiab] OR tamoxifen [tiab] OR aromatase inhibitor* [tiab] OR letrozole [tiab] OR arimidex [tiab] OR exemestane [tiab] OR estrogen receptor* [tiab] OR androgen receptor* [tiab] OR hormone receptor* [tiab] OR tumor progress* [tiab] OR transcriptional regulat* [tiab] OR gene expression profile* [tiab] OR transcriptional profile* [tiab] OR gender effect* [tiab] OR BRCA1 [tiab] OR BRCA2 [tiab]) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/
5. Mannen met borstkanker en erfelijkheid/genetica
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab]) AND ((genetic* [tiab] OR gene [tiab] OR genes [tiab]) AND (hereditar* [tiab] OR family [tiab] OR families [tiab] OR familial [tiab] OR counsel* [tiab] OR predict* [tiab] OR test [tiab] OR tests [tiab] OR predispos* [tiab] OR testing [tiab] OR syndrome* [tiab] OR screen* [tiab]) OR hereditar* [tiab] OR (predict* [tiab] AND model* [tiab]) OR screening [tiab] OR cancer risk* [tiab]) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/
6. Mannen met borstkanker en oorzaken/risicofactoren
(“Breast Neoplasms, Male”[Mesh] OR male breast neoplasm[tiab] OR male breast neoplasms[tiab] OR male breast tumor[tiab] OR male breast tumors[tiab] OR male breast tumour[tiab] OR male breast tumours[tiab] OR male breast cancer[tiab] OR male breast cancers[tiab] OR (male [tiab] AND (breast malign* [tiab] OR breast oncolog* [tiab])) OR male breast carcinoma[tiab] OR male breast carcinomas[tiab])AND (“Causality”[Mesh] OR cause* [tiab] OR causalit* [tiab] OR causat* [tiab] OR reinforcing factor* [tiab] OR enabling factor* [tiab] OR predisposing factor* [tiab] OR predisposition* [tiab] OR risk factor* [tiab]) AND (English [la] OR Dutch [la])
Zoekblok kopiëren en link naar pubmed gebruiken: https://www.ncbi.nlm.nih.gov/pubmed/